Suchen und filtern

Gefundene Studien

ADJUBIL A Phase II study of immunotherapy with durvalumab and tremelimumab in combination with capecitabine or without capecitabine in ADJUvant situation for BILiary tract cancer AIO-HEP-0421/ass · In Rekrutierung Studie anzeigen

Break B5-BM-NSCLC Breaking the big Five Barriers of Brain Metastasis: A prospective phase II, open-label, multi-center trial of combined nivolumab, ipilimumab and bevacizumab together with 2 cycles of induction chemotherapy in patients with non-squamous non-small-cell lung cancer (NSCLC) metastatic to the brain (Break B5-BM NSCLC Trial) AIO-TRK-0220/ass · In Rekrutierung Studie anzeigen

AIO-SUP-0121 Quality Assurance on Anemia Management in Patients with Solid Tumors and Malignant Lymphoma - finished AIO-SUP-0121 · Rekrutierung beendet Studie anzeigen

MOONLIGHT Modified FOLFOX plus/minus Nivolumab and Ipilimumab vs. FLOT plus Nivolumab in patients with previously untreated advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction – A randomized phase 2 trial. [MOONLIGHT] AIO-STO-0417 · Rekrutierung beendet Studie anzeigen

FIRE-9/PORT Post-resection/ablation chemotherapy in patients with metastatic colorectal cancer (FIRE9/PORT) AIO-KRK-0418 · In Rekrutierung Studie anzeigen

GOBLET A phase 1 / 2 multiple-indication biomarker, safety, and efficacy study in advanced or metastatic Gastrointestinal cancers explOring treatment comBinations with peLarEorep and aTezolizumab AIO-KRK-0320ass · In Rekrutierung Studie anzeigen

ATOMIC Randomized trial of standard chemotherapy alone or combined with atezolizumab as adjuvant therapy for patients with stage III colon cancer and deficient DNA mismatch repair AIO-KRK-0317 · In Rekrutierung Studie anzeigen

FIRE-7 Impact of a centralized tumour board on secondary intervention rate in patients with RAS mutant metastatic colorectal cancer after first-line treatment with FOLFOXIRI plus bevacizumab (FIRE-7) AIO-KRK-0120 · In Rekrutierung Studie anzeigen

FIRE-8 Prospective, randomized, open, multicenter Phase II trial to investigate the efficacy of trifluridine/tipiracil plus panitumumab versus trifluridine/tipiracil plus bevacizumab
as first-line treatment of metastatic colorectal cancer AIO-KRK/YMO-0519 · In Rekrutierung Studie anzeigen

PIONEER Window of opportunity study of preoperative immunotherapy with atezolizumab (Tecentriq in local squamous cell carcinoma of the head and neck – an imCORE Study AIO-KHT-0220/ass · In Rekrutierung Studie anzeigen